DEF 14A

Company

Jaguar Health, Inc.

Filed

April 17, 2017

Period of Report

May 8, 2017

Accession Number

0001047469-17-002654

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →